Education
About Us
Working with TipRanks
Follow Us
Psychemedics (PMDI)
OTHER OTC:PMDI
PMDI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.11 - $3.25
Previous CloseN/A
Volume81.76K
Average Volume (3M)2.34K
Market Cap
$13.99M
Enterprise Value$13.44M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Aug 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,109,502
10 Day Avg. Volume1,905
30 Day Avg. Volume2,344
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.96
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Psychemedics News
PMDI FAQ
What was Psychemedics’s price range in the past 12 months?
Psychemedics lowest stock price was $1.11 and its highest was $3.25 in the past 12 months.
What is Psychemedics’s market cap?
Psychemedics’s market cap is $13.99M.
When is Psychemedics’s upcoming earnings report date?
Psychemedics’s upcoming earnings report date is Aug 12, 2025 which is 5 days ago.
How were Psychemedics’s earnings last quarter?
Currently, no data Available
Is Psychemedics overvalued?
According to Wall Street analysts Psychemedics’s price is currently Overvalued.
Does Psychemedics pay dividends?
Psychemedics does not currently pay dividends.
What is Psychemedics’s EPS estimate?
Psychemedics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Psychemedics have?
Psychemedics has 6,109,502 shares outstanding.
What happened to Psychemedics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Psychemedics?
Currently, no hedge funds are holding shares in PMDI
Company Description
Psychemedics
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.
Technical Analysis
Ownership Overview
38.48% Insiders
0.03% Mutual Funds
4.52% Other Institutional Investors
56.97% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---